Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -263,063 | -154,626 | -577,757 | -350,643 | -260,017 |
| Depreciation Amortization | 7,216 | 4,399 | 20,037 | 100,672 | 6,534 |
| Income taxes - deferred | -353 | -353 | -1,836 | -682 | -671 |
| Accounts receivable | -8,256 | -2,047 | -5,680 | -5,402 | -2,389 |
| Accounts payable and accrued liabilities | 25,142 | 18,233 | 9,870 | 5,710 | 1,427 |
| Other Working Capital | 64,092 | 30,642 | 69,551 | 25,986 | 1,079 |
| Other Operating Activity | 70,104 | 54,293 | 191,958 | -1,160 | 89,689 |
| Operating Cash Flow | $-105,118 | $-49,459 | $-293,857 | $-225,519 | $-164,348 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,770 | 1,770 | N/A | N/A | N/A |
| PPE Investments | -226 | -86 | -13,657 | -9,133 | -5,298 |
| Net Acquisitions | N/A | N/A | -14,861 | -14,351 | -10,094 |
| Investing Cash Flow | $1,544 | $1,684 | $-28,518 | $-23,484 | $-15,392 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 6,859 | 4,907 | 96,071 | 98,560 | 57,093 |
| Debt Issued | 24,000 | 9,600 | N/A | N/A | N/A |
| Debt Repayment | N/A | -3,557 | N/A | N/A | N/A |
| Common Stock Issued | 37,697 | 22,971 | 403,532 | 340,861 | 269,386 |
| Dividend Paid | -11 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 81,464 | 27,275 | -187,885 | -152,783 | -111,339 |
| Financing Cash Flow | $150,009 | $61,196 | $311,718 | $286,638 | $215,140 |
| Exchange Rate Effect | -320 | 600 | -2,374 | -3,614 | -1,720 |
| Beginning Cash Position | 23,634 | 23,634 | 36,665 | 36,665 | 36,665 |
| End Cash Position | 69,749 | 37,655 | 23,634 | 70,686 | 70,345 |
| Net Cash Flow | $46,115 | $14,021 | $-13,031 | $34,021 | $33,680 |
| Free Cash Flow | |||||
| Operating Cash Flow | -105,118 | -49,459 | -293,857 | -225,519 | -164,348 |
| Capital Expenditure | -226 | -86 | -13,657 | -9,133 | -5,298 |
| Free Cash Flow | -105,344 | -49,545 | -307,514 | -234,652 | -169,646 |